Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
196
-
Total shares
-
68.8M
-
Shares change
-
+3.49M
-
Total reported value, excl. options
-
$3.16B
-
Value change
-
+$157M
-
Put/Call ratio
-
0.49
-
Number of buys
-
99
-
Number of sells
-
-111
-
Price
-
$45.92
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2015
200 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2015.
IMPAX LABORATORIES INC - COM (IPXL) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.8M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.74M shares), Hound Partners, LLC (5.61M shares), BlackRock Fund Advisors (5.38M shares), VANGUARD GROUP INC (4.92M shares), FRANKLIN RESOURCES INC (3.34M shares), Pennant Capital Management, LLC (3.2M shares), Invesco Ltd. (3.07M shares), ARAVT GLOBAL LLC (3M shares), STATE STREET CORP (2.15M shares), and Slate Path Capital LP (1.84M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.